| Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway KC Ohaegbulam, A Assal, E Lazar-Molnar, Y Yao, X Zang Trends in molecular medicine 21 (1), 24-33, 2015 | 919 | 2015 |
| Autocrine and paracrine regulation by cytokines and growth factors in melanoma E Lázár-Molnár, H Hegyesi, S Tóth, A Falus Cytokine 12 (6), 547-554, 2000 | 567 | 2000 |
| Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosis E Lázár-Molnár, B Chen, KA Sweeney, EJ Wang, W Liu, J Lin, SA Porcelli, ... Proceedings of the National Academy of Sciences 107 (30), 13402-13407, 2010 | 353 | 2010 |
| Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2 E Lazar-Molnar, Q Yan, E Cao, U Ramagopal, SG Nathenson, SC Almo Proceedings of the National Academy of Sciences 105 (30), 10483-10488, 2008 | 280 | 2008 |
| A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens P Arora, A Baena, OA Karl, NK Saini, SS Kharkwal, MF Goldberg, ... Immunity 40 (1), 105-116, 2014 | 134 | 2014 |
| The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum E Lázár-Molnár, A Gácser, GJ Freeman, SC Almo, SG Nathenson, ... Proceedings of the National Academy of Sciences 105 (7), 2658-2663, 2008 | 131 | 2008 |
| Structure and T cell inhibition properties of B7 family member, B7-H3 V Vigdorovich, UA Ramagopal, E Lázár-Molnár, E Sylvestre, JS Lee, ... Structure 21 (5), 707-717, 2013 | 127 | 2013 |
| Sequence, structure, function, immunity: structural genomics of costimulation K Chattopadhyay, E Lazar‐Molnar, Q Yan, R Rubinstein, C Zhan, ... Immunological reviews 229 (1), 356-386, 2009 | 121 | 2009 |
| Paracrine and autocrine interactions in melanoma: histamine is a relevant player in local regulation A Falus, H Hegyesi, E Lázár-Molnár, Z Pós, V László, Z Darvas Trends in immunology 22 (12), 648-652, 2001 | 76 | 2001 |
| Tissue-expressed B7-H1 critically controls intestinal inflammation L Scandiuzzi, K Ghosh, KA Hofmeyer, YM Abadi, E Lázár-Molnár, EY Lin, ... Cell reports 6 (4), 625-632, 2014 | 75 | 2014 |
| Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy E Lázár-Molnár, L Scandiuzzi, I Basu, T Quinn, E Sylvestre, E Palmieri, ... EBioMedicine 17, 30-44, 2017 | 67 | 2017 |
| Autoimmune NMDA receptor encephalitis E Lazar-Molnar, AE Tebo Clinica chimica acta 438, 90-97, 2015 | 64 | 2015 |
| Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin‐6 E Lázár‐Molnár, H Hegyesi, E Pállinger, P Kovács, S Tóth, C Fitzsimons, ... European journal of clinical investigation 32 (10), 743-749, 2002 | 61 | 2002 |
| A Monoclonal Antibody to Histoplasma capsulatum Alters the Intracellular Fate of the Fungus in Murine Macrophages L Shi, PC Albuquerque, E Lazar-Molnar, X Wang, L Santambrogio, ... Eukaryotic cell 7 (7), 1109-1117, 2008 | 43 | 2008 |
| Histamine deficiency induces tissue-specific down-regulation of histamine H2 receptor expression in histidine decarboxylase knockout mice CP Fitzsimons, E Lazar-Molnar, Z Tomoskozi, E Buzás, ES Rivera, ... FEBS letters 508 (2), 245-248, 2001 | 38 | 2001 |
| The interchain disulfide linkage is not a prerequisite but enhances CD28 costimulatory function E Lazar-Molnar, SC Almo, SG Nathenson Cellular immunology 244 (2), 125-129, 2006 | 34 | 2006 |
| Immunogenicity assessment of tumor necrosis factor antagonists in the clinical laboratory E Lazar-Molnar, JC Delgado Clinical chemistry 62 (9), 1186-1198, 2016 | 33 | 2016 |
| HLA genotyping in the clinical laboratory: comparison of next‐generation sequencing methods T Profaizer, E Lázár‐Molnár, DW Close, JC Delgado, A Kumánovics Hla 88 (1-2), 14-24, 2016 | 31 | 2016 |
| Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line N Szincsak, H Hegyesi, J Hunyadi, G Martin, E Lazar-Molnar, P Kovacs, ... Melanoma Research 12 (3), 231-240, 2002 | 31 | 2002 |
| Clinical laboratory application of a reporter-gene assay for measurement of functional activity and neutralizing antibody response to infliximab IY Pavlov, J Carper, E Lázár-Molnár, JC Delgado Clinica Chimica Acta 453, 147-153, 2016 | 27 | 2016 |
András Falus, Professor, PhD, DSc, m...Professor of Immunology and Genomics, Semmelweis University在 dgci.sote.hu 的电子邮件经过验证
